4//SEC Filing
Gabay Avraham 4
Accession 0001213900-25-012238
CIK 0001176309other
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 4:30 PM ET
Size
6.8 KB
Accession
0001213900-25-012238
Insider Transaction Report
Form 4
Gabay Avraham
Chief Financial Officer
Transactions
- Award
Common Stock
2025-02-11+34,000→ 392,040 total - Award
Common Stock
2025-02-11+42,000→ 434,040 total
Footnotes (2)
- [F1]Represents shares issued on settlement of performance stock units ("PSUs") previously granted on June 20, 2024 that vested on February 11, 2025 based on the achievement of the applicable performance criteria.
- [F2]Represents shares issued on settlement of PSUs previously granted on January 2, 2025 that vested on February 11, 2025 based on the achievement of the applicable performance criteria.
Documents
Issuer
ORAMED PHARMACEUTICALS INC.
CIK 0001176309
Entity typeother
Related Parties
1- filerCIK 0001777328
Filing Metadata
- Form type
- 4
- Filed
- Feb 10, 7:00 PM ET
- Accepted
- Feb 11, 4:30 PM ET
- Size
- 6.8 KB